Abacus life and lorisco life announce launch of preadisan™ to improve health predictions

Orlando, fla and new york, aug. 19, 2024 (globe newswire) -- abacus life, inc. (“abacus”) (nasdaq: abl), a pioneering alternative asset manager specializing in longevity and actuarial technology, and lorisco life llc (“lorisco”), a health prediction company using modern proteomics and machine learning to accurately forecast health events, today announced a new partnership and product launch to revolutionize longevity-based health prediction and actuarial technology.
ABL Ratings Summary
ABL Quant Ranking